Suggestions
Ibraheem Mahmood
Pharmaceutical Entrepreneur
Ibraheem Mahmood is a prominent figure in the field of healthcare and pharmaceuticals with a diverse and extensive background.
He studied Medicine at the prestigious University of Oxford, showcasing his strong educational foundation in the medical field.
Ibraheem Mahmood currently serves as the Chief Executive Officer and Co-founder of AMO Pharma LTD, demonstrating his leadership and entrepreneurial skills.
Prior to his role at AMO Pharma LTD, he was actively involved in various organizations and held key positions, including Co-founder and investor at Induction Healthcare Group PLC, Entrepreneur In Residence at Oxford Sciences Innovation, and Senior Vice President, Global Head, Clinical Technology Business at IQVIA.
His career has been marked by successful ventures and leadership roles, having also served as Chairman and Co-founder of AMO Pharma LTD, President and CEO of DrugDev, and in roles at Shire Pharmaceuticals, Investec, Aga Khan Health Service Pakistan, Nomura, and Accenture.
With his diverse experience across healthcare, pharmaceuticals, technology, and investments, Ibraheem Mahmood is a versatile professional who has made significant contributions to the industry.
Highlights
Hello Everyone. I want to introduce you to Sara Miller who runs Education for the Children Foundation (EFTC). As we say in Ireland, she is CLASS. If you’re USA based, please do your good deed for today and ping her on LinkedIn and hear what she has to say or at the very least share this among your network.
EFTC provides quality education and crucial support services to over 600 students from backgrounds of extreme poverty in Guatemala. She will be in New York City tomorrow (May 15th) to the 19th. She would love the opportunity to meet with both individuals and corporations to share more about her organization. A big focus of her visit is getting people to join the Nurture Network, just recently launched. By joining, you give students the tools they need to overcome the tremendous obstacles on their road to graduation.
You can join the network here https://lnkd.in/ecisNAnS and learn more about EFTC here www.eftcfoundation.org/
We all benefited from privileged educations so let’s push it forward!
Very excited to announce highly affirming data from our recent potential pivotal trial in congenital myotonic dystrophy.
